Crohn’s and Menopause: What to Know

How Does Menopause Affect Crohn’s Disease?

How Does Menopause Affect Crohn’s Disease?
iStock
By
Published on September 11, 2025
by
Menopause affects reproductive hormone levels, which can prompt changes in Crohn’s disease symptoms. Research shows the clearest connection between hormonal fluctuations during monthly menstrual cycles, but very few studies have explored how menopause influences Crohn’s.

 Still, the connection makes sense to many experts.

“We do have data suggesting a clear link between [estrogen and progesterone] and immune regulation, gut motility, barrier function, and microbiome balance,” says Omar Khokhar, MD, a gastroenterologist at OSF HealthCare in Bloomington, Illinois. “Since the pathophysiology of IBD is closely linked to the above, any change in hormone levels can trigger symptoms.”

Recognizing and addressing the connection between menopause and Crohn’s disease can lead to more effective, holistic care, says Ekta Gupta, MBBS, the chief of gastroenterology at the University of Maryland Medical Center in Baltimore.

“Also, as providers, we must validate patients' experiences — many women report feeling dismissed when discussing how menopause affects their GI symptoms,” says Dr. Gupta. More collaboration between clinicians, patients, and researchers can improve care for women experiencing menopause with Crohn’s, she adds.

What Is Menopause?

Menopause describes the transition away from regular menstruation and is considered complete once you haven’t had a period in 12 consecutive months.

 Most women start this process between ages 45 and 55. Once menopause is complete, periods stop and pregnancy becomes impossible.

During this transition, levels of hormones like estrogen and progesterone decline.

 And, while not all women experience uncomfortable menopausal effects, these hormone changes can cause symptoms like:

Beyond the more noticeable symptoms, hormonal decline in menopause can also cause a downturn in bone density and heart health. For most women, menopause symptoms last between two and eight years.

How Does Menopause Affect Crohn’s Disease?

Hormones like estrogen may help with gastrointestinal (GI) inflammation and the gut microbiome, so their decline may prompt more severe Crohn’s symptoms.

 “[But] studies on the relationship between menopause and inflammatory bowel disease (IBD) have shown mixed, inconclusive results,” says Adalberto Gonzalez, MD, a gastroenterologist with Cleveland Clinic in Florida.

“On the one hand, women with Crohn’s disease whose symptoms worsened with fluctuating estrogen levels during their menstrual cycles may find relief after menopause because of an overall decrease in estrogen levels,” says Dr. Gonzalez. On the other hand, decreased levels of estrogen and progesterone from menopause may cause GI symptoms similar to those of Crohn’s disease, he says.

Menopause and Crohn’s Symptoms May Overlap

“Menopause and Crohn’s disease may have overlapping gastrointestinal symptoms, such as abdominal bloating and pain, gas, nausea, indigestion, constipation, and diarrhea,” says Gonzalez.

While hot flashes and night sweats are hallmark menopausal symptoms, they can worsen fatigue and impact quality of life for someone with Crohn’s. “Conversely, Crohn’s-related inflammation, pain, or malabsorption can exacerbate mood swings, bone loss, and vaginal dryness commonly seen in menopause,” says Gupta.

Menopause May Start Earlier With Crohn’s Disease

Limited evidence suggests Crohn’s disease may cause menopause to start at an earlier age, says Gonzalez. One small study of 171 women found that participants with an IBD like Crohn’s started menopause an average of a year and a half earlier than those without an IBD.

Both Crohn’s and Menopause May Affect Mental Health

Both Crohn’s and menopause can cause mood changes. Mental health support is vital, as both Crohn’s and menopause are associated with increased anxiety and depression, says Gupta.

 “In general, menopause affects the general psyche of a woman, and can directly impact the brain-gut axis,” says Gupta.

Crohn’s and Menopause May Both Increase Osteoporosis Risk

Crohn’s can often lead to malnutrition, which, over time, can lead to low bone density from lack of dietary calcium. In addition, people who’ve had to take the steroid prednisone for Crohn’s flares have an increased risk for osteoporosis.

Similarly, menopause can make bones weaker, and women who have gone through this transition are at a higher risk for osteoporosis, with or without an IBD.

Hormone Replacement Therapy Shows Some Promise, but May Have Risks

Typically used to treat falling hormone levels during menopause, hormone replacement therapy (HRT) may have some therapeutic uses for women experiencing this transition alongside Crohn’s. One small study of 37 people with Crohn’s who used HRT postmenopause noticed an improvement in their IBD symptoms.

“[But] a recent systematic review revealed that few studies have examined menopause or hormone replacement therapy (HRT) in relation to IBD,” says Gonzalez. “Some studies associated HRT with an increased risk of IBD, while others illustrated an improvement in IBD symptoms.”

Another study of 447 patients with IBD and breast and prostate cancer found HRT actually caused IBD flares.

 But a larger study of more than 10,000 women suggests that HRT use postmenopause doesn’t increase IBD symptoms.

For some, it may be worth the risk. “Both Crohn’s disease and menopause can predispose women to osteoporosis and depression, and the use of HRT may help with treatment of these conditions,” says Gonzalez.

Gupta doesn’t recommend HRT for managing Crohn’s disease itself, but also doesn’t discourage its use for menopausal symptoms if needed. “I believe more research is needed, particularly prospective, well-controlled studies that account for disease phenotype, biologic use, and hormonal fluctuations over time,” she says. “Until then, individual risk-benefit discussions with shared decision-making are key when considering hormone therapy in women with Crohn’s.”

Individualized Management of Crohn’s and Menopause Is Critical

Experts emphasize the importance of individualized management for each person experiencing menopause with Crohn’s disease. “For example, a known HRT risk includes blood clots, and so it may be best to avoid HRT use in those with active Crohn’s disease or the use of Crohn’s medication associated with thromboembolism, such as tofacitinib,” says Gonzalez.

While core Crohn’s treatments typically don’t change with menopause, this hormonal shift should prompt some additional considerations. “[For example,] bone health monitoring is crucial, especially in patients currently on corticosteroids or with a remote history of corticosteroid use and a history of malabsorption,” says Gupta. “I often recommend DEXA scans (bone imaging) and ensure adequate calcium and vitamin D intake.”

Lifestyle Factors Can Help Both Menopausal and Crohn’s Symptoms

For both menopause and Crohn’s disease, lifestyle changes can reduce uncomfortable symptoms. “Clean eating and daily exercise are simple building blocks,” says Dr. Khokhar.

For improved symptoms of menopause and Crohn’s disease, try these healthy habits:

  • Limit or avoid nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen.
  • Try to exercise (a walk or jog) daily or most days of the week and do muscle-strengthening exercises at least twice a week.

  • Maintain a healthy weight.
  • Limit or avoid alcohol.
  • If you smoke, stop. If you need help quitting, ask your doctor for recommendations.

“Some of these lifestyle changes may be more difficult to maintain during menopause,” says Gonzalez. “For example, decreased estrogen may lead to weight gain, which has been associated with worse outcomes in IBD.” Women with joint pain after menopause may be inclined to use NSAIDs for pain relief, which [may also be] associated with IBD flares, says Gonzales.

If you have difficulty with any of these habits, or need help finding a treatment plan and lifestyle that’s both realistic and effective, ask your healthcare provider for their recommendations.

The Takeaway

  • Menopause may affect Crohn’s disease by increasing inflammation and altering the gut microbiome and immune system, but more research is needed to prove the connection.
  • Crohn’s disease and menopause have overlapping symptoms, like bloating, nausea, and diarrhea. Together, they may increase the risk of osteoporosis and mental health conditions like depression and anxiety.
  • Treatment for Crohn’s during menopause should be highly individualized.
  • Alongside treatment, paying attention to lifestyle factors like diet and exercise can help improve symptoms of both.

Resources We Trust

EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Kale T et al. Menopause and Inflammatory Bowel Disease: Systematic Review. Inflammatory Bowel Diseases. February 2025.
  2. Moktan VP et al. A Cohort Study of the Age at Menopause in Female Patients With and Without Inflammatory Bowel Disease. Crohn's & Colitis 360. 2022.
  3. What Is Menopause? NIH National Institute on Aging. October 16, 2024.
  4. Menopause. MedlinePlus. September 13, 2024.
  5. Peacock K et al. Menopause. StatPearls. December 21, 2023.
  6. Im EO et al. Gastrointestinal Symptoms in Four Major Racial/Ethnic Groups of Midlife Women: Race/Ethnicity and Menopausal Status. Menopause. 2021.
  7. Freeman M et al. Hormone Replacement Therapy Is Associated with Disease Activity Improvement among Post-Menopausal Women with Inflammatory Bowel Disease. Journal of Clinical Medicine. 2024.
  8. Rolston VS et al. The Influence of Hormonal Fluctuation on Inflammatory Bowel Disease Symptom Severity—A Cross-Sectional Cohort Study. Inflammatory Bowel Diseases. January 2018.
  9. Armuzzi A et al. Female Reproductive Health and Inflammatory Bowel Disease: A Practice-Based Review. Digestive and Liver Disease. January 2022.
  10. Symptoms & Causes of Crohn’s Disease. National Institute of Diabetes and Digestive and Kidney Diseases. July 2024.
  11. Zanoli L et al. Anxiety, Depression, Chronic Inflammation and Aortic Stiffness in Crohn’s Disease: The Brain--Gut--Vascular Axis. Journal of Hypertension. 2020.
  12. Pavlovska OM et al. Vasomotor Menopausal Disorders as a Possible Result of Dysfunction of the Microbiota-Intestine-Brain Axis. Journal of Medicine and Life. 2022.
  13. Nitkin K. Crohn’s and Ulcerative Colitis Pose Special Concerns for Women. Johns Hopkins University. 2020.
  14. Axelrad JE et al. Hormone Therapy for Cancer Is a Risk Factor for Relapse of Inflammatory Bowel Diseases. Clinical Gastroenterology and Hepatology. 2020.
  15. Tseng YT et al. Association of Hormone Replacement Therapy with Inflammatory Bowel Disease Risk in Women with Menopausal Disorders: A Population-Based Retrospective Cohort Study. Healthcare. 2025.
  16. Bartocci B et al. Mental Illnesses in Inflammatory Bowel Diseases: mens sana in corpore sano. Medicina. 2023.
  17. LaVasseur C et al. Hormonal Therapies and Venous Thrombosis: Considerations for Prevention and Management. Research and Practice in Thrombosis and Haemostasis. 2022.
  18. Liu E et al. Tofacitinib and Newer JAK Inhibitors in Inflammatory Bowel Disease — Where We Are and Where We Are Going. Drugs in Context. 2022.
  19. Lifestyle Changes for Menopause. NYU Langone Hospitals.
  20. Peifer R. IBD Risk Factors: What Causes Crohn’s & Colitis? Crohn's & Colitis Foundation. July 21, 2025.
  21. Exercise for Your Bone Health. National Institute of Arthritis and Musculoskeletal and Skin Diseases. May 2023.
Meet Our Experts
See Our Editorial PolicyMeet Our Health Expert Network

Yuying Luo, MD

Medical Reviewer

Yuying Luo, MD, is an assistant professor of medicine at Mount Sinai West and Morningside in New York City. She aims to deliver evidence-based, patient-centered, and holistic care for her patients.

Her clinical and research focus includes patients with disorders of gut-brain interaction such as irritable bowel syndrome and functional dyspepsia; patients with lower gastrointestinal motility (constipation) disorders and defecatory and anorectal disorders (such as dyssynergic defecation); and women’s gastrointestinal health.

She graduated from Harvard with a bachelor's degree in molecular and cellular biology and received her MD from the NYU Grossman School of Medicine. She completed her residency in internal medicine at the Icahn School of Medicine at Mount Sinai, where she was also chief resident. She completed her gastroenterology fellowship at Mount Sinai Hospital and was also chief fellow.

See full bio

Abby McCoy, RN

Author

Abby McCoy is an experienced registered nurse who has worked with adults and pediatric patients encompassing trauma, orthopedics, home care, transplant, and case management. She is a married mother of four and loves the circus — that is her home! She has family all over the world, and loves to travel as much as possible.

McCoy has written for publications like Remedy Health Media, Sleepopolis, and Expectful. She is passionate about health education and loves using her experience and knowledge in her writing.

See full bio
See Our Editorial PolicyMeet Our Health Expert Network